InnovAge stockholders price secondary offering of 10M shares at $9.25

InnovAge Holding Corp. (Nasdaq: INNV) announced the pricing of an underwritten secondary offering of 10,000,000 shares of common stock at $9.25 per share, with the shares being sold by investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe.

InnovAge is not selling any shares in the offering and will not receive any proceeds from the sale. The company will bear the costs associated with the offering, excluding underwriting discounts and commissions.

The selling stockholders have granted underwriters a 30-day option to purchase up to an additional 1,500,000 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on September 24, 2026, subject to customary closing conditions.

Barclays, Goldman Sachs & Co. LLC and Wells Fargo Securities are acting as lead book-running managers. UBS Investment Bank, William Blair and KeyBanc Capital Markets are serving as book-running managers. Academy Securities and Ramirez & Co., Inc. are co-managers for the offering.

As of June 30, 2026, InnovAge served approximately 8,230 participants across 20 centers in six states through the Program of All-inclusive Care for the Elderly.

You May Also Be Interested In

• BNY prices $1.25 billion preferred stock depositary share offering
• Logia USA signs Midwest distribution deal for fuel maintenance systems
• CoMira Diagnostics invited to Saudi manufacturing forum in November